Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 1

Abstract

Sorafenib is an oral multikinase inhibitor used as a palliative intent for advanced hepatocellular carcinoma (HCC). Dermatologic toxicity is the main adverse effect limiting its use in many patients. However, Grade III dermatologic toxicity is rarely seen with low-dose sorafenib administration. Here, we discuss the case of a 72-year-old male patient who was treated with sorafenib 400 mg for HCC. After 18 days of administration, the patient complained of intense pain with blisters and ulcerations. The drug was discontinued, and topical corticosteroids and analgesics were given for the management. Review of the patient’s medication did not reveal the presence of any other possible drugs capable of producing dermatological toxicity.

Authors and Affiliations

Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Anila K N

Keywords

Related Articles

Chronomorphological and pressure changes in a sign of aging - pseudoexfoliation of the eye

Background: Pseudoexfoliation (PXE) is an age-related disorder, a risk factor for glaucoma. The aim of this research was to study the chronomorphological and pressure changes in PXE of the eye. Aims and Objectives: To de...

Electrophysiological evaluation in patients with type 2 diabetes mellitus by pattern reversal visual evoked potentials

Background: A more general involvement of the nervous system in diabetes, affecting not only the peripheral but also the central nervous system has been increasingly suggested over the last two decades. Electrophysiologi...

A study of awareness about human immunodeficiency virus/acquired immunodeficiency syndrome among first-year MBBS students of KBNIMS, Gulbarga

Background: Acquired immunodeficiency syndrome (AIDS) is characterized by reduction in a number of T-helper cells, because of infection by human immunodeficiency virus (HIV). HIV affects the immune system and, therefore,...

Immediate effect of contract-relax antagonist-contract method on iliopsoas muscle and hamstring muscle stretching in chronic non-specific low back pain

Background: Low back pain (LBP) is a common musculoskeletal problem in recent days, and 85% of LBP is NSLBP. Studies have shown that psoas syndrome can be the cause of pain in lumbosacral region in a clinical scenario. A...

Impact of horizontal and vertical integration: Learning and perception in first-year medical students

Background: Medical field and its curriculum is dynamic in nature which keeps on adding huge data each year, thus overburdening the students with content information. Most of the colleges in India teach subject in isolat...

Download PDF file
  • EP ID EP450364
  • DOI 10.5455/njppp.2018.8.0725025072017
  • Views 68
  • Downloads 0

How To Cite

Nithu M Kumar, Priyanka Sreelatha, Shine Sadasivan, Anila K N (2018). Sorafenib-induced dermatologic Grade III toxicity: An important clinical manifestation. National Journal of Physiology, Pharmacy and Pharmacology, 8(1), 144-145. https://europub.co.uk/articles/-A-450364